Gromadzka G, Antos A, Sorysz Z, Litwin T
Int J Mol Sci. 2024; 25(22).
PMID: 39596417
PMC: 11595239.
DOI: 10.3390/ijms252212354.
Zhou Y, Bai L, Tang W, Yang W, Sun L
Heliyon. 2024; 10(12):e33458.
PMID: 39027435
PMC: 11254713.
DOI: 10.1016/j.heliyon.2024.e33458.
Motamedi H, Mahdizade Ari M, Alvandi A, Abiri R
Front Microbiol. 2024; 15:1393646.
PMID: 38939184
PMC: 11208694.
DOI: 10.3389/fmicb.2024.1393646.
Moaveni A, Amiri M, Shademan B, Farhadi A, Behroozi J, Nourazarian A
Front Mol Biosci. 2024; 11:1382190.
PMID: 38836106
PMC: 11149429.
DOI: 10.3389/fmolb.2024.1382190.
Caponnetto A, Ferrara C, Fazzio A, Agosta N, Scribano M, Vento M
Genes (Basel). 2024; 15(1).
PMID: 38275605
PMC: 10815046.
DOI: 10.3390/genes15010124.
Role of regulatory non-coding RNAs in traumatic brain injury.
Li S, Qiu N, Ni A, Hamblin M, Yin K
Neurochem Int. 2023; 172:105643.
PMID: 38007071
PMC: 10872636.
DOI: 10.1016/j.neuint.2023.105643.
A comprehensive prognostic and immunological analysis of telomere-related lncRNAs in kidney renal clear cell carcinoma.
Chen J, Zhang D, Ren X, Wang P
Aging (Albany NY). 2023; 15(20):11012-11032.
PMID: 37847171
PMC: 10637817.
DOI: 10.18632/aging.205056.
Differentially expressed non-coding RNAs and their regulatory networks in liver cancer.
Moldogazieva N, Zavadskiy S, Astakhov D, Sologova S, Margaryan A, Safrygina A
Heliyon. 2023; 9(9):e19223.
PMID: 37662778
PMC: 10474437.
DOI: 10.1016/j.heliyon.2023.e19223.
Clinical relevance of circulating non-coding RNAs in metabolic diseases: Emphasis on obesity, diabetes, cardiovascular diseases and metabolic syndrome.
Dandare A, Khan M, Naeem A, Liaquat A
Genes Dis. 2023; 10(6):2393-2413.
PMID: 37554181
PMC: 10404886.
DOI: 10.1016/j.gendis.2022.05.022.
The impact and role of identified long noncoding RNAs in nonalcoholic fatty liver disease: A narrative review.
Shi N, Sun K, Tang H, Mao J
J Clin Lab Anal. 2023; 37(11-12):e24943.
PMID: 37435630
PMC: 10431402.
DOI: 10.1002/jcla.24943.
Comprehensive analysis of the coding and non-coding RNA transcriptome expression profiles of hippocampus tissue in tx-J animal model of Wilson's disease.
Wang D, Xie D, Zhang J, Cai B, Yang B, Zhou L
Sci Rep. 2023; 13(1):9252.
PMID: 37286730
PMC: 10247767.
DOI: 10.1038/s41598-023-36503-8.
Integrative analysis of TP53 mutations in lung adenocarcinoma for immunotherapies and prognosis.
Li H, Yang L, Wang Y, Wang L, Chen G, Zhang L
BMC Bioinformatics. 2023; 24(1):155.
PMID: 37072703
PMC: 10114340.
DOI: 10.1186/s12859-023-05268-2.
Targeting Non-Coding RNA for CNS Injuries: Regulation of Blood-Brain Barrier Functions.
Zhang L, Bai W, Sun L, Lin Y, Tian M
Neurochem Res. 2023; 48(7):1997-2016.
PMID: 36786944
DOI: 10.1007/s11064-023-03892-1.
Potential role of long noncoding RNA RP5-881L22.5 as a novel biomarker and therapeutic target of colorectal cancer.
Zong H, Zou J, Huang J, Huang S
World J Gastrointest Oncol. 2022; 14(11):2108-2121.
PMID: 36438707
PMC: 9694279.
DOI: 10.4251/wjgo.v14.i11.2108.
LncRNA LINC02257: A Potential Biomarker for Diagnosis and Prognosis of Colorectal Cancer.
Chen M, Li C, Luo Q, Tan A
J Oncol. 2022; 2022:4330630.
PMID: 36124032
PMC: 9482534.
DOI: 10.1155/2022/4330630.
Identification of Core Genes and Screening of Potential Targets in Intervertebral Disc Degeneration Using Integrated Bioinformatics Analysis.
Li J, Yu C, Ni S, Duan Y
Front Genet. 2022; 13:864100.
PMID: 35711934
PMC: 9196128.
DOI: 10.3389/fgene.2022.864100.
CTB-193M12.5 Promotes Hepatocellular Carcinoma Progression via Enhancing NSD1-Mediated WNT10B/Wnt/β-Catenin Signaling Activation.
Zhang S, Jiang M, Cao H, Xiong J, Xu J
J Hepatocell Carcinoma. 2022; 9:553-569.
PMID: 35698644
PMC: 9188405.
DOI: 10.2147/JHC.S365302.
miR-155: An Important Role in Inflammation Response.
Hu J, Huang S, Liu X, Zhang Y, Wei S, Hu X
J Immunol Res. 2022; 2022:7437281.
PMID: 35434143
PMC: 9007653.
DOI: 10.1155/2022/7437281.
Non-coding RNAs in the regulation of blood-brain barrier functions in central nervous system disorders.
Sun P, Hamblin M, Yin K
Fluids Barriers CNS. 2022; 19(1):27.
PMID: 35346266
PMC: 8959280.
DOI: 10.1186/s12987-022-00317-z.
KB-68A7.1 Inhibits Hepatocellular Carcinoma Development Through Binding to NSD1 and Suppressing Wnt/β-Catenin Signalling.
Zhang S, Xu J, Cao H, Jiang M, Xiong J
Front Oncol. 2022; 11:808291.
PMID: 35127520
PMC: 8810504.
DOI: 10.3389/fonc.2021.808291.